This statement consists of forward-searching statements in the which means in the non-public Securities Litigation Reform Act of 1995 which have been subject to risks, uncertainties and various variables, which includes Gilead’s ability to initiate, progress and total medical trials inside the anticipated timelines or in the slightest degree, and